Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutations causing neurodegenerative tauopathies.

Michel Goedert1, Ross Jakes

  • 1MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK. mg@mrc-lmb.ac.uk

Biochimica Et Biophysica Acta
|December 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Pick fold in tau filaments from human MAPT mutants.

Acta neuropathologica·2026
Same author

Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments.

eLife·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Seeding biosensor cell line that reproduces the Alzheimer tau fold.

The Journal of biological chemistry·2025
Same author

Author Correction: Structures of α-synuclein filaments from multiple system atrophy.

Nature·2025

Mutations in the Tau gene cause neurodegenerative diseases like frontotemporal dementia (FTD). These mutations lead to abnormal tau protein filaments and nerve cell degeneration, informing new disease models.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Tau protein forms intracellular filaments in neurodegenerative diseases, including Alzheimer's disease (AD) and frontotemporal dementia (FTD).
  • The causal relationship between tau dysfunction and disease onset was unclear until tau gene mutations were linked to FTD.
  • Numerous tau gene mutations have been identified, impacting protein function or RNA splicing.

Purpose of the Study:

  • To investigate the role of tau gene mutations in neurodegenerative diseases.
  • To understand how tau mutations lead to abnormal protein aggregation and disease phenotypes.
  • To develop accurate animal models for studying human tauopathies.

Main Methods:

  • Genetic analysis of tau gene mutations in affected families.

Related Experiment Videos

  • Biochemical studies on the effects of mutations on tau protein structure and function.
  • Development of animal models mimicking human tauopathies.

    • Main Results:

    • 32 distinct tau gene mutations identified in over 100 families.
    • Mutations affect tau's interaction with microtubules and promote filament assembly.
    • RNA-level mutations alter tau isoform ratios, leading to overproduction of specific tau variants.
    • Tau mutations can cause disease phenotypes resembling progressive supranuclear palsy and corticobasal degeneration.
    • The H1 haplotype of the tau gene is a risk factor for certain tauopathies.

    Conclusions:

    • Tau gene mutations are causative agents of specific neurodegenerative diseases.
    • Understanding mutation mechanisms provides insight into tauopathy pathogenesis.
    • Experimental animal models are crucial for studying tauopathies and developing therapeutics.